Missing outcomes in randomized trials: addressing the dilemma

Douglas G Altman. Open Med. 2009.

. 2009 May 12;3(2):e51-3.

No abstract available

Conflict of interest statement

Competing interests: None declared.

Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review.
Molnar FJ, Man-Son-Hing M, Hutton B, Fergusson DA. Molnar FJ, et al. Open Med. 2009 Mar 24;3(2):e31-50. Open Med. 2009. PMID: 19946392 Free PMC article.

1. Moher D, Schulz K F, Altman D CONSORT Group. The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285(15):1987–1991. http://jama.ama-assn.org/cgi/content/full/285/15/1987. - PubMed
1. Montori V M, Guyatt G H. Intention-to-treat principle. CMAJ. 2001;165(10):1339–41. http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=11760981. - PMC - PubMed
1. Altman Douglas G, Bland J Martin. Missing data. BMJ. 7590;334(7590):424. doi: 10.1136/bmj.38977.682025.2C. projects/linkout/nsh/nsh_display.cgi?PrId=5914&PmId=17322261&Code=tu&JrI.... - DOI - PMC - PubMed
1. Wood Angela M, White Ian R, Thompson Simon G. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials. 2004;1(4):368–376. - PubMed
1. Salim Agus, Mackinnon Andrew, Christensen Helen, Griffiths Kathleen. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates. Psychiatry Res. 2008 Aug 20;160(3):335–345. doi: 10.1016/j.psychres.2007.08.005. - DOI - PubMed